Molina Healthcare (NYSE:MOH - Free Report) had its target price reduced by Robert W. Baird from $405.00 to $331.00 in a research note released on Thursday morning, Benzinga reports. They currently have an outperform rating on the stock.
A number of other analysts also recently issued reports on MOH. StockNews.com upgraded shares of Molina Healthcare from a "hold" rating to a "buy" rating in a report on Friday, October 18th. Wells Fargo & Company lifted their price objective on shares of Molina Healthcare from $315.00 to $360.00 and gave the company an "equal weight" rating in a report on Monday, August 5th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $406.00 price objective on shares of Molina Healthcare in a report on Tuesday, October 1st. Stephens reiterated an "equal weight" rating and issued a $320.00 price objective on shares of Molina Healthcare in a report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Molina Healthcare from $354.00 to $353.00 and set a "hold" rating on the stock in a report on Monday, July 29th. One research analyst has rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Molina Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $371.83.
Check Out Our Latest Stock Report on Molina Healthcare
Molina Healthcare Stock Up 17.7 %
MOH traded up $48.59 during trading on Thursday, reaching $323.59. The company had a trading volume of 2,711,152 shares, compared to its average volume of 520,343. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57. Molina Healthcare has a 12 month low of $272.69 and a 12 month high of $423.92. The business's fifty day moving average price is $336.17 and its 200 day moving average price is $330.51. The company has a market cap of $18.96 billion, a P/E ratio of 18.00, a PEG ratio of 1.15 and a beta of 0.58.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share for the quarter, beating analysts' consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The firm had revenue of $9.88 billion for the quarter, compared to analyst estimates of $9.75 billion. During the same quarter in the previous year, the firm posted $5.65 earnings per share. The business's revenue was up 18.7% on a year-over-year basis. Equities analysts anticipate that Molina Healthcare will post 23.5 EPS for the current year.
Insider Buying and Selling at Molina Healthcare
In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now directly owns 18,025 shares in the company, valued at $6,114,260.25. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now directly owns 18,025 shares in the company, valued at $6,114,260.25. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Maurice Hebert sold 393 shares of the company's stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company's stock.
Institutional Investors Weigh In On Molina Healthcare
Institutional investors have recently modified their holdings of the business. CWM LLC boosted its position in shares of Molina Healthcare by 76.2% in the third quarter. CWM LLC now owns 4,001 shares of the company's stock valued at $1,379,000 after acquiring an additional 1,730 shares during the period. Cetera Investment Advisers lifted its position in Molina Healthcare by 516.4% during the first quarter. Cetera Investment Advisers now owns 10,238 shares of the company's stock worth $4,206,000 after purchasing an additional 8,577 shares during the period. BI Asset Management Fondsmaeglerselskab A S lifted its position in Molina Healthcare by 69.5% during the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 11,809 shares of the company's stock worth $4,851,000 after purchasing an additional 4,840 shares during the period. BNP Paribas Financial Markets lifted its position in Molina Healthcare by 35.6% during the first quarter. BNP Paribas Financial Markets now owns 56,835 shares of the company's stock worth $23,350,000 after purchasing an additional 14,920 shares during the period. Finally, ProShare Advisors LLC lifted its position in Molina Healthcare by 28.4% during the first quarter. ProShare Advisors LLC now owns 10,352 shares of the company's stock worth $4,253,000 after purchasing an additional 2,288 shares during the period. Institutional investors own 98.50% of the company's stock.
About Molina Healthcare
(
Get Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.